Economic slowdown should not hamper global fund donations

With the new knowledge that providing antiretroviral (ARV) treatment to people living with HIV would "contribut[e] to a sharp slowdown in the spread of the virus," "scaling up treatment now may prove to be the least expensive option if we want to bring this deadly pandemic, which still infects 1.8 million people every year, under control," Michel Kazatchkine, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria writes in the Guardian's "Poverty Matters Blog."  

Kazatchkine notes that 6.5 million people are on ARV treatment because of the efforts of the Global Fund and PEPFAR. He writes, "The international community in June set itself the ambitious target of putting another nine million people on treatment by 2015, which would take the total receiving HIV treatment to 15 million. Raising the funding to meet the '15 by 15' goal is going to be very challenging at a time when the world is facing the biggest economic crisis since the great depression of the 1930s. … Some of our donors, including the U.S., France, Norway and Australia, have committed to increase their financial contributions to the Global Fund over the next three years. We hope that more countries follow their example" (8/5).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research shows how public criticism during COVID-19 impacted teacher wellbeing